LIVERPOOL -- Certain B3 lesion types and imaging characteristics have a higher risk of upgrading to a cancer within three years and should be considered for more regular screening. That's the view of researchers from a top London hospital who presented the results of a new 10-year study at the U.K. Imaging and Oncology Congress (UKIO).